Cited by 603Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.

Selective vulnerability in neurodegenerative diseases

Open access

Fu, Hongjun, Hardy, John, Duff, Karen E.·2018·Nature Neuroscience

DOI 10.1038/s41593-018-0221-2PMC PMC6360529

Open this paper in CoChat — free account

Abstract

Neurodegenerative diseases have two general characteristics that are so fundamental we usually take them for granted. The first is that the pathology associated with the disease only affects particular neurons ('selective neuronal vulnerability'); the second is that the pathology worsens with time and impacts more regions in a stereotypical and predictable fashion. The mechanisms underpinning selective neuronal and regional vulnerability have been difficult to dissect, but the recent application of whole-genome technologies, the development of mouse models that reproduce spatial and temporal features of the pathology, and the identification of intrinsic morphological, electrophysiological, and biochemical properties of vulnerable neurons are beginning to shed some light on these fundamental features of neurodegenerative diseases. Here we detail our emerging understanding of the underlying biology of selective neuronal vulnerability and outline some of the areas in which our understanding is incomplete.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41593-018-0221-2

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.
Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268
Cryo-EM structures of tau filaments from Alzheimer’s disease
Fitzpatrick, A. W. P., Falcon, B., He, S., Murzin, A. G., Murshudov, G., Garringer, H. J., Crowther, R. A., Ghetti, B., Goedert, M., & Scheres, S. H. W. (2017) · Nature · doi:10.1038/nature23002 · Cited by 2,061
Ionic dependence of glutamate neurotoxicity
Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854

Show all 154 references

Research works printed but not linked: 1

Nitrini, R. Selective vulnerability of von Economo neurons in frontotemporal dementia. Dement. Neuropsychol. 2, 164 (2008).

Sorted by citations

Items 101–200 of 603

Sex differences in Alzheimer’s disease: metabolic reprogramming and therapeutic intervention
Demetrius, L., Eckert, A., & Grimm, A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.09.004 · Cited by 52
Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes
Okkels, N., Grothe, M. J., Taylor, J., Hasselbalch, S. G., Fedorova, T. D., Knudsen, K., van der Zee, S., van Laar, T., Bohnen, N. I., Borghammer, P., et al. (2024) · Brain · doi:10.1093/brain/awae069 · Cited by 53
Astrocytes in selective vulnerability to neurodegenerative disease
Zimmer, T. S., Orr, A. L., & Orr, A. G. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.02.008 · Cited by 57
Cross-disorder and disease-specific pathways in dementia revealed by single-cell genomics
Rexach, J. E., Cheng, Y., Chen, L., Polioudakis, D., Lin, L., Mitri, V., Elkins, A., Han, X., Yamakawa, M., Yin, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.019 · Cited by 59
iPSC for modeling neurodegenerative disorders
Valadez-Barba, V., Cota-Coronado, A., Hernandez-Perez, O. R., Lugo-Fabres, P. H., Padilla‐Camberos, E., Díaz, N. F., & Diaz-Martinez, N. E. (2020) · Regenerative Therapy · doi:10.1016/j.reth.2020.11.006 · Cited by 49
Mitochondrial protein dysfunction in pathogenesis of neurological diseases
Wang, L., Yang, Z., He, X., Pu, S., Yang, C., Wu, Q., Zhou, Z., Cen, X., & Zhao, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.974480 · Cited by 48
Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies
Kumar, D., Ambasta, R. K., & Kumar, P. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101078 · Cited by 51
Neuroprotective effects of naturally sourced bioactive polysaccharides: an update
Le, W., Xu, X.-L., Li, S., & Zhang, R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335142 · Cited by 50
Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer’s pathology
Kumar, P., Goettemoeller, A. M., Espinosa‐García, C., Tobin, B. R., Tfaily, A., Nelson, R. S., Natu, A., Dammer, E. B., Santiago, J. V., Malepati, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47028-7 · Cited by 53
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington’s Disease
Ellis, N., Tee, A., McAllister, B., Massey, T. H., McLauchlan, D. J., Stone, T., Correia, K., Loupe, J. M., Kim, K., Barker, D., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.010 · Cited by 48
Modelling neurodegenerative disease using brain organoids
Wray, S. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.05.012 · Cited by 45
Human tau mutations in cerebral organoids induce a progressive dyshomeostasis of cholesterol
Glasauer, S. M. K., Goderie, S. K., Rauch, J. N., Guzman, E., Audouard, M., Bertucci, T., Joy, S., Rommelfanger, E., Luna, G., Keane-Rivera, E., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.07.011 · Cited by 46
Epidemiology of neurodegenerative diseases in the East African region: A meta-analysis
Onohuean, H., Akiyode, A. O., Akiyode, O. O., Igbinoba, S. I., & Alagbonsi, A. I. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1024004 · Cited by 49
Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases
Moosavi, S. G., Rahiman, N., Jaafari, M. R., & Arabi, L. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113641 · Cited by 54
Microglial TMEM119 binds to amyloid-β to promote its clearance in an Aβ-depositing mouse model of Alzheimer’s disease
Liu, J., Wang, Z., Liang, W., Zhang, Z., Deng, Y., Chen, X., Hou, Z., Xie, Y., Wang, Q., Li, Y., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.04.018 · Cited by 47
Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease
Spencer, B. J., Trinh, I., Rockenstein, E. M., Mante, M., Florio, J. B., Adame, A., El‐Agnaf, O. M. A., Kim, C., Masliah, E., & Rissman, R. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.001 · Cited by 48
Neuroprotective potential of extracts from leaves of ora-pro-nobis (Pereskia aculeata) recovered by clean compressed fluids
Torres, T. M. S., Álvarez‐Rivera, G., Mazzutti, S., Sánchez-Martínez, J. D., Cifuentes, A., Ibáñez, E., & Ferreira, S. R. S. (2021) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2021.105390 · Cited by 44
Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
Ottoy, J., Kang, M. S., Tan, J. X. M., Boone, L., de Wael, R. V., Park, B., Bezgin, G., Lussier, F. Z., Pascoal, T. A., Rahmouni, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49300-2 · Cited by 56
Glutamine Metabolism: Molecular Regulation, Biological Functions, and Diseases
Kumar, M. A., Baba, S. K., Khan, I. R., Khan, M. S., Husain, F. M., Ahmad, S., Haris, M., Singh, M., Akil, A. A., Macha, M. A., et al. (2025) · MedComm · doi:10.1002/mco2.70120 · Cited by 52
α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson’s Disease Models
Bi, M., Du, X., Jiao, Q., Liu, Z., & Jiang, H. F. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00196 · Cited by 44
Parvalbumin-Positive Neuron Loss and Amyloid-β Deposits in the Frontal Cortex of Alzheimer’s Disease-Related Mice
Ali, F., Baringer, S. L., Neal, A., Choi, E. Y., & Kwan, A. C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181190 · Cited by 43
Striatal circuit development and its alterations in Huntington's disease
Lebouc, M., Richard, Q., Garret, M., & Baufreton, J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105076 · Cited by 45
Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS
Kao, C. S., van Bruggen, R., Kim, J. R., Chen, X. X., Chan, C., Lee, J., Cho, W. I., Zhao, M., Arndt, C., Maksimovic, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18949-w · Cited by 41
Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy
Sahara, N., & Yanai, R. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1149761 · Cited by 46
Microglia Drive Pockets of Neuroinflammation in Middle Age
Moca, E. N., Lecca, D., Hope, K. T., Etienne, F., Schaler, A. W., Espinoza, K., Chappell, M. S., Gray, D. T., Tweedie, D., Sidhu, S., et al. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.1922-21.2022 · Cited by 42
Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy
Forrest, S. L., Lee, S., Nassir, N., Martínez-Valbuena, I., Sackmann, V., Li, J., Ahmed, A., Tartaglia, M. C., Ittner, L. M., Lang, A. E., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02604-x · Cited by 44
Deletion of Topoisomerase 1 in excitatory neurons causes genomic instability and early onset neurodegeneration
Fragola, G., Mabb, A. M., Taylor‐Blake, B., Niehaus, J. K., Chronister, W. D., Mao, H., Simon, J. M., Yuan, H., Li, Z., McConnell, M. J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15794-9 · Cited by 43
Tubulin polyglutamylation, a regulator of microtubule functions, can cause neurodegeneration
Bodakuntla, S., Janke, C., & Magiera, M. M. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135656 · Cited by 40
Heterotypic Amyloid β interactions facilitate amyloid assembly and modify amyloid structure
Konstantoulea, K., Guerreiro, P. S., Ramakers, M., Louros, N. N., Aubrey, L. D., Houben, B., Michiels, E., Vleeschouwer, M. D., Lampi, Y., Ribeiro, L. F., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108591 · Cited by 39
A transdiagnostic review of neuroimaging studies of apathy and disinhibition in dementia
Jenkins, L. M., Wang, L., Rosen, H. J., & Weıntraub, S. (2022) · Brain · doi:10.1093/brain/awac133 · Cited by 40
Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis
Kaminiów, K., Kozak, S., & Paprocka, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105729 · Cited by 39
Disrupting pathologic phase transitions in neurodegeneration
Hurtle, B. T., Xie, L., & Donnelly, C. J. (2023) · Journal of Clinical Investigation · doi:10.1172/jci168549 · Cited by 40
Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease
Šimić, G., Španić, E., Horvat, L. L., & Hof, P. R. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.003 · Cited by 40
Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
La‐Rocque, S. D., Moretto, E., Butnaru, I., & Schiavo, G. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15144 · Cited by 46
MicroRNA‐183‐5p is stress‐inducible and protects neurons against cell death in amyotrophic lateral sclerosis
Li, C., Chen, Y., Chen, X., Wei, Q., Ou, R., Gu, X., Cao, B., & Shang, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15490 · Cited by 38
Repeat RNA expansion disorders of the nervous system: post-transcriptional mechanisms and therapeutic strategies
Schwartz, J. L., Jones, K. L., & Yeo, G. W.-M. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1841726 · Cited by 36
Wolframin is a novel regulator of tau pathology and neurodegeneration
Chen, S., Acosta, D. M., Li, L., Liang, J., Chang, Y., Wang, C., Fitzgerald, J., Morrison, C. T., Goulbourne, C. N., Nakano, Y., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02417-4 · Cited by 40
Self-citation
Interaction of Neuromelanin with Xenobiotics and Consequences for Neurodegeneration; Promising Experimental Models
Capucciati, A., Zucca, F. A., Monzani, E., Zecca, L., Casella, L., & Hofer, T. (2021) · Antioxidants · doi:10.3390/antiox10060824 · Cited by 36
3D printing of functional bioengineered constructs for neural regeneration: a review
Zhu, H., Yao, C., Wei, B.-Y., Xu, C., Huang, X., Liu, Y., He, J., Zhang, J., & Li, D. (2023) · International Journal of Extreme Manufacturing · doi:10.1088/2631-7990/ace56c · Cited by 39
Function of WFS1 and WFS2 in the Central Nervous System: Implications for Wolfram Syndrome and Alzheimer’s disease
Li, L., Venkataraman, L., Chen, S., & Fu, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.011 · Cited by 37
Self-citation
Insight into the role of phosphatidylserine in complement-mediated synapse loss in Alzheimer’s disease
Sokolova, D., Childs, T., & Hong, S. Y. (2021) · Faculty Reviews · doi:10.12703/r/10-19 · Cited by 35
The penalty of stress ‐ Epichaperomes negatively reshaping the brain in neurodegenerative disorders
Ginsberg, S. D., Joshi, S., Sharma, S., Guzman, G., Wang, T., Arancio, O., & Chiosis, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15525 · Cited by 38
Effects of Polyphenols in Aging and Neurodegeneration Associated with Oxidative Stress
Rivas, F., Poblete-Aro, C., Pando, M. E., Allel, M. J., Fernández, V. S., Soto, A., Nova-Baeza, P., & García‐Díaz, D. F. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666211101100632 · Cited by 37
Tissue Clearing and Expansion Methods for Imaging Brain Pathology in Neurodegeneration: From Circuits to Synapses and Beyond
Parra‐Damas, A., & Saura, C. A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00914 · Cited by 35
Functionally distinct Purkinje cell types show temporal precision in encoding locomotion
Chang, W., Pedroni, A., Hohendorf, V., Giacomello, S., Hibi, M., Köster, R. W., & Ampatzis, K. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2005633117 · Cited by 39
The Role of Hub Neurons in Modulating Cortical Dynamics
Gal, E., Amsalem, O., Schindel, A., London, M., Schürmann, F., Markram, H., & Segev, I. (2021) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.718270 · Cited by 33
Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
Manos, J. D., Preiss, C. N., Venkat, N., Tamm, J., Reinhardt, P., Kwon, T., Wu, J., Winter, A. D., Jahn, T. R., Yanamandra, K., et al. (2022) · iScience · doi:10.1016/j.isci.2021.103658 · Cited by 36
Specific cortical and subcortical grey matter regions are associated with insomnia severity
Falgàs, N., Illán‐Gala, I., Allen, I. E., Mumford, P., Essanaa, Y. M., Le, M. M., You, M. Y., Grinberg, L. T., Rosen, H. J., Neylan, T. C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252076 · Cited by 33
Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation
Arbo, B. D., Schimith, L. E., dos Santos, M. G., & Hort, M. A. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.174800 · Cited by 33
Framework Nucleic Acid Nanomaterials for Central Nervous System Therapies: Design for Barrier Penetration, Targeted Delivery, Cellular Uptake, and Endosomal Escape
Chen, X., Luo, X., Yin, W., Cui, W., He, Y., Tian, T., & Lin, Y. (2025) · ACS Nano · doi:10.1021/acsnano.5c03945 · Cited by 39
Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate
Weber, J. J., Clemensson, L. E., Schiöth, H. B., & Nguyen, H. P. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.002 · Cited by 38
Heterotypic interactions in amyloid function and disease
Konstantoulea, K., Louros, N. N., Rousseau, F., & Schymkowitz, J. W. H. (2021) · FEBS Journal · doi:10.1111/febs.15719 · Cited by 34
Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer’s Disease and Mild Cognitive Impairment
King‐Robson, J., Initiative, A. D. N., Wilson, H., & Politis, M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201457 · Cited by 29
Boosting mitochondrial health to counteract neurodegeneration
Burtscher, J., Romani, M., Bernardo, G., Popa, T., Ziviani, E., Hummel, F. C., Sorrentino, V., & Millet, G. P. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102289 · Cited by 36
Novel methodology for detection and prediction of mild cognitive impairment using resting‐state EEG
Deng, J., Sun, B., Kavcic, V., Liu, M., Giordani, B., & Li, T. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13411 · Cited by 31
Non-Coding RNAs as Sensors of Oxidative Stress in Neurodegenerative Diseases
Gámez‐Valero, A., Guisado-Corcoll, A., Herrero‐Lorenzo, M., Solaguren‐Beascoa, M., & Martí, E. (2020) · Antioxidants · doi:10.3390/antiox9111095 · Cited by 34
On the Right Track to Treat Movement Disorders: Promising Therapeutic Approaches for Parkinson’s and Huntington’s Disease
Troncoso-Escudero, P., Sepúlveda, D., Pérez-Arancibia, R., Parra, A. V., Arcos, J., Grünenwald, F., & Vidal, R. L. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.571185 · Cited by 31
Early alterations of neurovascular unit in the retina in mouse models of tauopathy
Xia, F., Ha, Y., Shi, S., Li, Y., Li, S., Luisi, J. D., Kayed, R., Motamedi, M., Liu, H., & Zhang, W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01149-y · Cited by 30
Patient-specific models link neurotransmitter receptor mechanisms with motor and visuospatial axes of Parkinson’s disease
Khan, A. F., Adewale, Q., Lin, S.-J., Baumeister, T. R., Zeighami, Y., Carbonell, F., Palomero-Gallagher, N., & Iturria-Medina, Y. (2023) · Nature Communications · doi:10.1038/s41467-023-41677-w · Cited by 28
Intracellular accumulation of amyloid-ß is a marker of selective neuronal vulnerability in Alzheimer’s disease
Caramello, A., Fancy, N. N., Tournerie, C., Eklund, M., Chau, V. M. N., Adair, E., Papageorgopoulou, M., Willumsen, N., Jackson, J., Hardy, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60328-w · Cited by 37
Self-citation
A manual multiplex immunofluorescence method for investigating neurodegenerative diseases
Ehrenberg, A. J., Morales, D. O., Piergies, A. M. H., Li, S. H., Tejedor, J. S., Mladinov, M., Mulder, J., & Grinberg, L. T. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108708 · Cited by 34
Modeling Neurological Disorders in 3D Organoids Using Human-Derived Pluripotent Stem Cells
Bose, R., Banerjee, S., & Dunbar, G. L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.640212 · Cited by 30
Role of aging in Blood–Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19
Adesse, D., Gladulich, L., Alvarez-Rosa, L., Siqueira, M., Marcos, A. C., Heider, M., Motta, C. S., Torices, S., Toborek, M. J., & Stipursky, J. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00357-5 · Cited by 30
Blood RNA transcripts reveal similar and differential alterations in fundamental cellular processes in Alzheimer's disease and other neurodegenerative diseases
Huseby, C. J., Delvaux, E., Brokaw, D. L., & Coleman, P. D. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12880 · Cited by 26
Spinal Cord Organoids to Study Motor Neuron Development and Disease
Buchner, F., Dokuzluoglu, Z., Graß, T., & Rodríguez‐Muela, N. (2023) · Life · doi:10.3390/life13061254 · Cited by 28
Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers
Louros, N., Ramakers, M., Michiels, E., Konstantoulea, K., Morelli, C., Garcia, T., Moonen, N., D’Haeyer, S., Goossens, V., Thal, D. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28955-9 · Cited by 28
Formation of toxic oligomers of polyQ-expanded Huntingtin by prion-mediated cross-seeding
Gropp, M., Klaips, C. L., & Hartl, F. U. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.031 · Cited by 28
Mushroom Polysaccharides as Potential Candidates for Alleviating Neurodegenerative Diseases
Jiang, X., Li, S., Feng, X., Li, L., Hao, J., Wang, D., & Wang, Q. (2022) · Nutrients · doi:10.3390/nu14224833 · Cited by 29
Single-Cell Sequencing in Neurodegenerative Disorders
Pozojevic, J., & Spielmann, M. (2023) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-023-00668-9 · Cited by 30
A holo-spectral EEG analysis provides an early detection of cognitive decline and predicts the progression to Alzheimer’s disease
Chu, K.-T., Lei, W.-C., Wu, M., Fuh, J., Wang, S., French, I. T., Chang, W.-S., Chang, C., Huang, N. E., Liang, W., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1195424 · Cited by 28
Beyond the usual suspects: multi-factorial computational models in the search for neurodegenerative disease mechanisms
Khan, A. F., & Iturria‐Medina, Y. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03073-w · Cited by 31
Dynamic nanoassemblies for imaging and therapy of neurological disorders
Zhang, L., Sun, H., Zhao, J., Lee, J., Low, L. E., Gong, L., Chen, Y., Wang, N., Zhu, C., Lin, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113832 · Cited by 27
Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views
Kanel, P., Bédard, M., Aghourian, M., Rosa‐Neto, P., Soucy, J., Albin, R. L., & Bohnen, N. I. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-021-01140-z · Cited by 27
The reactivity of copper complexes with neuronal peptides promoted by catecholamines and its impact on neurodegeneration
Bacchella, C., Dell’Acqua, S., Nicolis, S., Monzani, E., & Casella, L. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214756 · Cited by 27
Nanoscale imaging of pT217‐tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early‐stage neurodegeneration
Datta, D., Perone, I., Wijegunawardana, D., Liang, F., Morozov, Y. M., Arellano, J. I., Duque, A., Xie, Z., van Dyck, C. H., Joyce, M. K. P., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13737 · Cited by 28
Selective vulnerability and resilience to Alzheimer's disease tauopathy as a function of genes and the connectome
Anand, C., Abdelnour, F., Sipes, B. S., Ma, D., Maia, P. D., Torok, J., & Raj, A. (2025) · Brain · doi:10.1093/brain/awaf179 · Cited by 29
The role of exosomes in adult neurogenesis: implications for neurodegenerative diseases
Yu, Z., Teng, Y., Yang, J., & Yang, L. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.379036 · Cited by 26
Impairment of entorhinal cortex network activity in Alzheimer’s disease
Karimani, F., Taei, A. A., Abolghasemi-Dehaghani, M.-R., Safari, M.-S., & Dargahi, L. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1402573 · Cited by 27
P62 accumulates through neuroanatomical circuits in response to tauopathy propagation
de Thé, F.-X. B., Lassus, B., Schaler, A. W., Fowler, S. L., Goulbourne, C. N., Jeggo, R., la Cour, C. M., Millan, M. J., & Duff, K. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01280-w · Cited by 28
Self-citation
The role of efferocytosis in neuro-degenerative diseases
Taheri, F., Taghizadeh, E., Navashenaq, J. G., Rezaee, M., & Gheibihayat, S. M. (2022) · Neurological Sciences · doi:10.1007/s10072-021-05835-6 · Cited by 25
Nose-to-Brain: The Next Step for Stem Cell and Biomaterial Therapy in Neurological Disorders
Villar-Gómez, N., Ojeda-Hernández, D. D., López-Muguruza, E., García-Flores, S., Bonel-García, N., Benito‐Martín, M. S., Selma-Calvo, B., Canales-Aguirre, A. A., Mateos‐Díaz, J. C., Montero‐Escribano, P., et al. (2022) · Cells · doi:10.3390/cells11193095 · Cited by 26
Multidimensional autophagy nano-regulator boosts Alzheimer's disease treatment by improving both extra/intraneuronal homeostasis
Li, Y., Yang, P., Meng, R., Xu, S., Zhou, L., Qian, K., Wang, P., Cheng, Y., Sheng, D., Xu, M., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.10.009 · Cited by 26
Betz cells of the primary motor cortex
Nolan, M., Scott, C., Hof, P. R., & Ansorge, O. (2024) · The Journal of Comparative Neurology · doi:10.1002/cne.25567 · Cited by 27
Non-canonical pathways associated to Amyloid beta and tau protein dyshomeostasis in Alzheimer’s disease: A narrative review
Maggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 24
Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1
Chopra, R., Bushart, D. D., Cooper, J.-P. R., Yellajoshyula, D., Morrison, L. M., Huang, H.-R., Handler, H. P., Man, L.-K. J., Dansithong, W., Scoles, D., et al. (2020) · bioRxiv · doi:10.1093/hmg/ddaa212 · Cited by 27
Investigating binding mechanism of thymoquinone to human transferrin, targeting Alzheimer's disease therapy
Xue, B., DasGupta, D., Alam, M., Khan, M. S., Wang, S., Shamsi, A., Islam, A., & Hassan, M. I. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30299 · Cited by 25
Distinct translatome changes in specific neural populations precede electroencephalographic changes in prion-infected mice
Kaczmarczyk, L., Schleif, M., Dittrich, L., Williams, R. H., Koderman, M., Bansal, V., Rajput, A., Schulte, T., Jonson, M., Krost, C., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010747 · Cited by 21
Erucic Acid: A Possible Therapeutic Agent for Neurodegenerative Diseases
Goyal, A., Dubey, N., Verma, A., & Agrawal, A. (2023) · Current Molecular Medicine · doi:10.2174/1566524023666230509123536 · Cited by 24
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer’s disease
Vilkaite, G., Vogel, J. W., & Mattsson, N. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101735 · Cited by 25
Divergent actions of physiological and pathological amyloid-β on synapses in live human brain slice cultures
McGeachan, R. I., Meftah, S., Taylor, L. W., Catterson, J. H., Negro, D., Bonthron, C., Holt, K., Tulloch, J., Rose, J. L., Gobbo, F., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58879-z · Cited by 23
Neurodegenerative Diseases and Cholesterol: Seeing the Field Through the Players
Pfrieger, F. W. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.766587 · Cited by 22
Region‐specific preservation of Purkinje cell morphology and motor behavior in the ATXN1[82Q] mouse model of spinocerebellar ataxia 1
White, J. J., Bosman, L. W. J., Blot, F. G. C., Osório, C., Kuppens, B. W., Krijnen, W. H. J. J., Andriessen, C. A., Zeeuw, C. I. D., Jaarsma, D., & Schonewille, M. (2021) · Brain Pathology · doi:10.1111/bpa.12946 · Cited by 22
Transfer RNA processing – from a structural and disease perspective
Sekulovski, S., & Trowitzsch, S. (2022) · Biological Chemistry · doi:10.1515/hsz-2021-0406 · Cited by 23
Predicting longitudinal brain atrophy in Parkinson’s disease using a Susceptible-Infected-Removed agent-based model
Abdelgawad, A., Rahayel, S., Zheng, Y., Tremblay, C., Vo, A., Mišić, B., & Dagher, A. (2022) · Network Neuroscience · doi:10.1162/netn_a_00296 · Cited by 22
Potential therapeutic effects of baicalin and baicalein.
Sabry, K., Jamshidi, Z., Emami, S. A., & Sahebka, A. (2024) · PubMed Central · doi:10.22038/ajp.2023.22307 · Cited by 22
A metastable subproteome underlies inclusion formation in muscle proteinopathies
Ciryam, P., Antalek, M. D., Cid, F., Tartaglia, G. G., Dobson, C. M., Güttsches, A., Eggers, B., Vorgerd, M., Marcus, K., Kley, R. A., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0853-9 · Cited by 21
Potential Mechanisms of Tunneling Nanotube Formation and Their Role in Pathology Spread in Alzheimer’s Disease and Other Proteinopathies
Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 24
Efficient derivation of excitatory and inhibitory neurons from human pluripotent stem cells stably expressing direct reprogramming factors
Song, S., Ashok, A., Williams, D. J., Kaufman, M. E., Duff, K., & Sproul, A. A. (2021) · Current Protocols · doi:10.1002/cpz1.141 · Cited by 16
Self-citation
Heterotypic amyloid interactions: Clues to polymorphic bias and selective cellular vulnerability?
Louros, N. N., Schymkowitz, J. W. H., & Rousseau, F. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.11.007 · Cited by 19

Authors: Fu, H., Hardy, J., & Duff, K. E.
Affiliations: Columbia University Irving Medical Center (US)
UCL Queen Square Institute of Neurology (GB)
Corresponding author: Duff, Karen E.
ORCID: Fu, Hongjun
Hardy, John
Duff, Karen E.
Venue: Nature Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2018-09-24
Volume: 21
Issue: 10
Pages: 1350-1358
ISSN: 1097-6256 (ISSN-L)
1546-1726
DOI: 10.1038/s41593-018-0221-2
PMC: PMC6360529
OpenAlex: W2890004445
Cited by: 585
References: 154
Citations by year: 2026: 87 · 2025: 78 · 2024: 85 · 2023: 67 · 2022: 83 · 2021: 82 · 2020: 60 · 2019: 39 · 2018: 3
FWCI: 6.05
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature Neuroscience (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
UCL Discovery (University College London) (submittedVersion)
Funders: National Institute on Aging (RF1AG056151, K01AG056673)
National Institute of Neurological Disorders and Stroke (R01NS074874)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: neurodegenerative diseases, selective neuronal vulnerability, regional vulnerability, disease progression
MeSH terms: Animals, Humans, Neurons, Neurodegenerative Diseases, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Selective vulnerability in neurodegenerative diseases

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks